Company
Apogee Therapeutics, Inc. (APGE)
Standardized SEC financial data for Apogee Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001974640 · NASDAQ · Biological Products, (No Diagnostic Substances).
Free cash flow
-$232.6M
Current ratio
26.57×
EPS (diluted)
$-4.22
Income statement
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| R&D expense | $27.8M | $68.4M | $167.9M | $214.7M |
| SG&A expense | $2.9M | $24.6M | $49.0M | $70.9M |
| Operating income |
Standardized from Apogee Therapeutics, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $151.9M | $118.6M | $142.1M | $131.5M |
| Total current assets | $152.1M | $398.4M | $529.7M | $741.4M |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$16.4M | -$74.8M | -$171.2M | -$227.4M |
| Capital expenditures | — | $167K | $1.2M | $5.1M |
Get APGE data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/APGE/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/APGE/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"